ONKORISKTM TEST Options

OnkoRisk’s streamlined test menu focuses on genes with definitive or well-established guideline-based evidence of clinical utility. OnkoRisk panels have been carefully curated by a board certified team of molecular pathologists, clinical molecular geneticists, and genetic counselors.

Testing options available:

Test code: TP68-3 (Non-NYS Only)

BRCA1
BRCA2

Test code: TP65-9 (Non-NYS Only)

APC
ATM
BMPR1A
BRCA1
BRCA2
CDH1
CHEK2
EPCAM
MLH1
MSH2
MSH6
MUTYH
PALB2
PMS2
PTEN
STK11
TP53

Test Code: TP66-7 (Non-NYS Only)

ATM
BARD1
BRCA1
BRCA2
BRIP1
CDH1
CHEK2
EPCAM
HOXB13
MLH1
MSH2
MSH6
PALB2
PMS2
PTEN
RAD51C
RAD51D
STK11
TP53

†Panel may determine patient’s risk for prostate cancer.

Test Code: TP67-5 (Non-NYS Only)

ATM
BARD1
BRCA1
BRCA2
BRIP1
CDH1
CHEK2
EPCAM
MLH1
MSH2
MSH6
NF1
PALB2
PMS2
PTEN
RAD51C
RAD51D
STK11
TP53

*Panel may determine patient’s risk for breast, ovarian, and endometrial cancer.

APC
ATM
AXIN2
BAP1
BARD1
BMPR1A
BRCA1
BRCA2
BRIP1
CDH1
CDK4
CDKN1B
CDKN2A
CHEK2
EPCAM
FH
FLCN
GREM1
HOXB13
MAX
MEN1
MET
MLH1
MSH2
MSH3
MSH6
MUTYH
NF1
NF2
PALB2
PMS2
POLD1
POLE
PRKAR1A
PTCH1
PTEN
RAD51B
RAD51C
RAD51D
RB1
RET
SDHA
SDHAF2
SDHB
SDHC
SDHD
SMAD4
STK11
SUFU
TMEM127
TP53
TSC1
TSC2
VHL
WT1

Test Code: TP69-1 (Non-NYS Only)

ALK
 APC
 ATM
 AXIN2
 BAP1
 BARD1
 BLM
 BMPR1A
 BRCA1
 BRCA2
 BRIP1
 CDC73
 CDH1
 CDK4
 CDKN1B
 CDKN2A
 CHEK2
 CTNNA1
 DICER1
 EGFR
 EPCAM
 FANCA
 FANCC
 FANCD2
 FANCE
 FANCF
 FANCG
 FANCI
 FANCL
 FH
 FLCN
 GREM1
 HOXB13
 KIT
 LZTR1
 MAX
 MEN1
 MET
 MITF
 MLH1
 MSH2
 MSH3
 MSH6
 MUTYH
 NBN
 NF1
 NF2
 PALB2
 PDGFRA
 PHOX2B
 PMS2
 POLD1
 POLE
 PRKARA1
 PTCH1
 PTEN
 RAD51B
 RAD51C
 RAD51D
 RB1
 RET
 SDHA
 SDHAF2
 SDHB
 SDHC
 SDHD
 SMAD4
 SMARCA4
 SMARCB1
 STK11
 SUFU
 TMEM127
 TP53
 TSC1
 TSC2
 VHL
 WT1

Healthcare providers should only order panels if each gene or test in the panel is medically necessary.

OnkoRiskTM is pending NY State approval.